Table:
begin	end	state
1	573	cytoplasmic
574	594	transmembrane
595	731	non-cytoplasmic
732	754	transmembrane
755	780	cytoplasmic
781	802	transmembrane
803	809	non-cytoplasmic
810	832	transmembrane
833	838	cytoplasmic
839	858	transmembrane
859	900	non-cytoplasmic
901	921	transmembrane
922	926	cytoplasmic

Input:
>WP_092052478.1 NCBI__GCF_900111775.1:WP_092052478.1
MTSPAPSGEISKTPPVAQLRDVSLRYKKTQALDSISLDLPSGGMVGFIGPDGVGKSSLFS
LIAGARAIQTGSIDVLGGDMADRHHRRQVCPRVAYMPQGLGKNLYPTLSVYENAEFFGRL
FGQDRQERQDRIDDLLAATGLSPFAGRPAGKLSGGMKQKLGLCCALIHDPDLLILDEPTT
GVDPLSRRQFWELIERIRHNRPGMSVLVATAYMEEAARFDWLVAMNGGRVLATGTPAELL
ERTGGESLEEAFIALLPEAQRESYEPIVIPPRNTDEDGQTAIEAQGLTMRFGDFTAVDHV
DFRILRGEIFGFLGSNGCGKTTTMKILTGLLPATEGEARLFGHKVNAHDIETRRRVGYMT
QGFSLYSELTVRQNLVLHARLFRMPEEKIPERVEEMAERFGLIGIMESLPDALPLGQRQR
LSLAVAMIHAPEMLILDEPTSGVDPVARDGFWRIMIDLARREKVTIFISTHFMNEALRCD
RISLMHAGKVLVSDAPRALMEKRGAATLEEAFISYLEEASAGPESAASPPPEKALPTPPA
PSRERQHHPAGFFSLRRLLSYTRRESLELRRDPIRLTLALLGTLILMFVIGYGVNMDVED
LTFAVLDRDQSALSRDYALNLSGSRYFIEHAPIRDYADMDRRMRAGEISLAIEIPPGFGR
DLRRGSAVAIGAWIDGAMPQRAETVRGYAQGMHAHWLASVSRQARGEASTSGTVNIETRF
RYNPDVKSLPSMVPAVIPLLLMMIPAMLTALSVVREKELGSIVNLYVTPVTRLEFLLGKQ
IPYLALAMLNFLLLTALAVFVFKVPITGSFTALSTGALLYVCAATTLGMVISTFMRSQIA
AIFGTAILTILPAVQFSGMLDPVSSLEGAGAVIGKIYPTTHFLTIARGTFSKALGFADLQ
ASFIPLLLAVPILIGLGAVLLKKQER

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server